• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SAN DIEGO, INC. INRATIO PT/INR TEST STRIPS; PROTHROMBIN TIME TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SAN DIEGO, INC. INRATIO PT/INR TEST STRIPS; PROTHROMBIN TIME TEST Back to Search Results
Model Number 100071
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problems Hemorrhage/Bleeding (1888); Ulcer (2274); Test Result (2695)
Event Date 03/03/2015
Event Type  Injury  
Event Description
"caller alleged discrepant results compared with the lab.Results as follows:" date: inratio: lab: (b)(6) 2015, ---, 9.0.(b)(6) 2015, --- , 7.4.(b)(6) 2015, 2.5 , ---.Patient self tester's therapeutic range is: 2.5-3.5.Patient self tester (pst) initially went to the hospital on (b)(6) 2015 for a check up on another admission that occurred three weeks prior for unspecified bleeding.It was discovered at that time that his hgb had dropped to around 4 something (exact value not available).The pst was given 6 unites of blood and was discharge three days later after determining bleed was due to small ulcers in his esophagus.Pst was admitted to the hospital on (b)(6) 2015 due to inr reading of 9.0 and was discharged on (b)(6) 2015.Pst had blood transfusions (including fresh frozen plasma) but confirmed no other treatments were provided.A repeat lab inr=7.4 was obtained on (b)(6) 2015; the following day inratio=2.5.Pst's warfarin was held between (b)(6) 2015 and dosage resumed on (b)(6) 2015.The next inr result was a lab result of 3.7 on (b)(6) 2015.
 
Manufacturer Narrative
Investigation pending.
 
Manufacturer Narrative
The products associated with the complaint were returned for investigation.The customer's complaint of discrepant low results was not confirmed during in-house testing.Retain and return strip testing on the returned meter met both accuracy and strip repeatability criteria.The returned meter met functional and thermistor testing requirements during investigation.A review of the manufacturing records for the strip lot did not uncover any non-conformances.The lot meets release specification.The impedance curve analysis associated with the customer's inratio inr result of 2.5 found that the curve exhibited a weak slope change.Our capa investigation (b)(4) has determined that impedance curves with weak slope change can cause discrepant results.The capa investigation has also determined that certain patient conditions can contribute to weak slope change impedance curves.The patient had prostate cancer and anemia with a hematocrit of 9.1% at the time of the alleged discrepant result.Capa (b)(4) has identified hospitalized or advanced stage cancer and anemia with hematocrit less than 30% both as conditions that may contribute to a discrepant inr result.A notification letter has been sent to customers to inform them of these patient conditions.A possible root cause for the complaint is the patient having the conditions of prostate cancer and anemia with a hematocrit of 9.1% which may have contributed to an impedance curve that exhibited a weak-slope change.The inratio meter software may generate an incorrect or discrepant inr result when the patient sample exhibits a weak-slope change impedance curve.Further investigation is being performed under capa (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INRATIO PT/INR TEST STRIPS
Type of Device
PROTHROMBIN TIME TEST
Manufacturer (Section D)
ALERE SAN DIEGO, INC.
9975 summers ridge rd.
san diego CA 92121
Manufacturer (Section G)
ALERE SAN DIEGO, INC.
9975 summers ridge rd.
san diego CA 92121
Manufacturer Contact
ya-ling king
9975 summers ridge rd.
san diego, CA 92121
8588052084
MDR Report Key4625053
MDR Text Key19810448
Report Number2027969-2015-00207
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K092987
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Distributor
Reporter Occupation Patient
Type of Report Initial,Followup
Report Date 03/05/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model Number100071
Device Lot Number348355
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/19/2015
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 04/02/2015
Initial Date FDA Received03/23/2015
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received04/09/2015
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
FUROSEMIDE; ATENELOL; ASPIRIN; INRATIO MONITOR SN: (B)(4); WARFARIN; ATORVASTATIN; OMEPRAZOLE; BICALUTIMIDE; LISINOPRI; IRON
Patient Outcome(s) Hospitalization; Required Intervention;
-
-